Clinical Trial Update: Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

View source ↗

Summary

This clinical trial update examines the effect of lomitapide on major adverse cardiovascular events in patients with homozygous familial hypercholesterolemia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Lomitapide (lomitapide)

Snippet

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | Conditions: Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE) | Status: ACTIVE_NOT_RECRUITING